Novo Nordisk launches UK’s first daily GLP-1 weight-loss pill

Novo Nordisk has launched a Wegovy pill, the UK’s first authorised daily oral GLP-1 treatment for weight management, giving eligible adults an alternative to injectable obesity medicines through regulated private providers